190 related articles for article (PubMed ID: 30546365)
1. Ginsenoside F1 Promotes Cytotoxic Activity of NK Cells via Insulin-Like Growth Factor-1-Dependent Mechanism.
Kwon HJ; Lee H; Choi GE; Kwon SJ; Song AY; Kim SJ; Choi WS; Hwang SH; Kim SC; Kim HS
Front Immunol; 2018; 9():2785. PubMed ID: 30546365
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of natural killer (NK) cell activity by methanol extract of cultured cambial meristematic cells of wild ginseng and its mechanism.
Jang AY; Song EJ; Shin SH; Hwang PH; Kim SY; Jin YW; Lee EK; Lim MJ; Oh IS; Ahn JY; Nam SY
Life Sci; 2015 Aug; 135():138-46. PubMed ID: 26141997
[TBL] [Abstract][Full Text] [Related]
3. The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity.
Zhang B; Zhou WJ; Gu CJ; Wu K; Yang HL; Mei J; Yu JJ; Hou XF; Sun JS; Xu FY; Li DJ; Jin LP; Li MQ
Cell Death Dis; 2018 May; 9(5):574. PubMed ID: 29760378
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rh2 enhances immune surveillance of natural killer (NK) cells via inhibition of ERp5 in breast cancer.
Yang C; Qian C; Zheng W; Dong G; Zhang S; Wang F; Wei Z; Xu Y; Wang A; Zhao Y; Lu Y
Phytomedicine; 2024 Jan; 123():155180. PubMed ID: 38043385
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside F1 promotes angiogenesis by activating the IGF-1/IGF1R pathway.
Zhang J; Liu M; Huang M; Chen M; Zhang D; Luo L; Ye G; Deng L; Peng Y; Wu X; Liu G; Ye W; Zhang D
Pharmacol Res; 2019 Jun; 144():292-305. PubMed ID: 31048033
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside 20(R)-Rg3 enhances natural killer cell activity by increasing activating receptor expression through the MAPK/ERK signaling pathway.
Lee Y; Park A; Park YJ; Jung H; Kim TD; Noh JY; Choi I; Lee S; Ran Yoon S
Int Immunopharmacol; 2022 Jun; 107():108618. PubMed ID: 35219164
[TBL] [Abstract][Full Text] [Related]
7. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.
Smyth MJ; Teng MW; Swann J; Kyparissoudis K; Godfrey DI; Hayakawa Y
J Immunol; 2006 Feb; 176(3):1582-7. PubMed ID: 16424187
[TBL] [Abstract][Full Text] [Related]
8. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
Yamasaki T; Moritake K; Klein G
J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
[TBL] [Abstract][Full Text] [Related]
9. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Kim N; Kim HS
Front Immunol; 2018; 9():2041. PubMed ID: 30250471
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I.
Solerte SB; Fioravanti M; Vignati G; Giustina A; Cravello L; Ferrari E
J Clin Endocrinol Metab; 1999 Sep; 84(9):3260-7. PubMed ID: 10487697
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Artemisinin on the Cytolytic Activity of Natural Killer (NK) Cells.
Houh YK; Kim KE; Park S; Hur DY; Kim S; Kim D; Bang SI; Yang Y; Park HJ; Cho D
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28737711
[TBL] [Abstract][Full Text] [Related]
12. Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.
Hsu J; Hodgins JJ; Marathe M; Nicolai CJ; Bourgeois-Daigneault MC; Trevino TN; Azimi CS; Scheer AK; Randolph HE; Thompson TW; Zhang L; Iannello A; Mathur N; Jardine KE; Kirn GA; Bell JC; McBurney MW; Raulet DH; Ardolino M
J Clin Invest; 2018 Oct; 128(10):4654-4668. PubMed ID: 30198904
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-host reactions in the beige mouse. An investigation of the role of host and donor natural killer cells in the pathogenesis of graft-versus-host disease.
Ghayur T; Seemayer TA; Kongshavn PA; Gartner JG; Lapp WS
Transplantation; 1987 Aug; 44(2):261-7. PubMed ID: 3307050
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 receptor (IGF-1R) inhibition promotes expansion of human NK cells which maintain their potent antitumor activity against Ewing sarcoma cells.
Jamitzky S; Krueger AC; Janneschuetz S; Piepke S; Kailayangiri S; Spurny C; Rossig C; Altvater B
Pediatr Blood Cancer; 2015 Nov; 62(11):1979-85. PubMed ID: 26131572
[TBL] [Abstract][Full Text] [Related]
15. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
[TBL] [Abstract][Full Text] [Related]
16. Human natural killer cells: a comprehensive review.
Sinkovics JG; Horvath JC
Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
[TBL] [Abstract][Full Text] [Related]
17. Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells.
Dewan MZ; Terunuma H; Toi M; Tanaka Y; Katano H; Deng X; Abe H; Nakasone T; Mori N; Sata T; Yamamoto N
Cancer Sci; 2006 Dec; 97(12):1381-7. PubMed ID: 16995875
[TBL] [Abstract][Full Text] [Related]
18. In vivo tumor cell rejection induced by NK cell inhibitory receptor blockade: maintained tolerance to normal cells even in the presence of IL-2.
Vahlne G; Lindholm K; Meier A; Wickström S; Lakshmikanth T; Brennan F; Wilken M; Nielsen R; Romagné F; Wagtmann NR; Kärre K; Johansson MH
Eur J Immunol; 2010 Mar; 40(3):813-23. PubMed ID: 20039300
[TBL] [Abstract][Full Text] [Related]
19. Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells.
Kitajima M; Ito T; Tumes DJ; Endo Y; Onodera A; Hashimoto K; Motohashi S; Yamashita M; Nishimura T; Ziegler SF; Nakayama T
Cancer Res; 2011 Jul; 71(14):4790-8. PubMed ID: 21646476
[TBL] [Abstract][Full Text] [Related]
20. Ginsenoside F1 Attenuates Eosinophilic Inflammation in Chronic Rhinosinusitis by Promoting NK Cell Function.
Kim SJ; Lee J; Choi WS; Kim HJ; Kim MY; Kim SC; Kim HS
J Ginseng Res; 2021 Nov; 45(6):695-705. PubMed ID: 34764724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
